Mar 22 |
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q4 2023 Earnings Call Transcript
|
Mar 22 |
Q4 2023 X4 Pharmaceuticals Inc Earnings Call
|
Mar 21 |
X4 Pharmaceuticals, Inc. (XFOR) Q4 2023 Earnings Call Transcript
|
Mar 21 |
X4 Pharmaceuticals Inc (XFOR) Reports Fourth-Quarter and Full-Year 2023 Financial Results
|
Mar 21 |
X4 Pharmaceuticals GAAP EPS of -$0.10 beats by $0.05
|
Mar 21 |
X4 Pharmaceuticals Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Corporate Update
|
Mar 20 |
X4 Pharmaceuticals Q4 2023 Earnings Preview
|
Mar 12 |
X4 Pharmaceuticals to Report Fourth-Quarter and Full Year 2023 Financial Results and Host a Conference Call and Webcast on March 21, 2024
|
Dec 15 |
XFOR: Update on Phase 2 CN Trial at ASH 2023
|
Dec 14 |
X4: Dip Following Mixed Results In Chronic Neutropenia Indication Worth Buying
|